Streetbeat News

Regulatory

PLTR

TSLA

Elon Musk and Joe Lonsdale discussed government efficiency on social media, with Musk inviting Lonsdale to join a proposed Department of Government Efficiency. The conversation highlighted potential cost savings through technology, referencing past attempts to use Palantir's software for government efficiency.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 7:29 am

BYDDF

BYDDY

GELYF

Chinese EV manufacturers, including BYD and Geely, are showcasing their products at the Frankfurt trade fair to counteract global trade barriers and expand their presence in international markets. Despite tariffs from the EU, US, and Canada, Chinese automakers are investing in overseas expansion and exploring new markets.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 7:22 am

AAPL

NVDA

ORCL

PLTR

TSLA

On Monday, U.S. indices closed positively, with notable movements in Palantir, Apple, Nvidia, Oracle, and Tesla stocks. Palantir surged due to its upcoming inclusion in the S&P 500. Apple had a marginal increase after launching the iPhone 16. Nvidia rose amid an antitrust investigation. Oracle fell despite strong earnings and new cloud partnerships. Tesla gained following Panasonic's EV battery production announcement.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 3:13 am

BIIB

LLY

NVDA

Eli Lilly (NYSE:LLY) has appointed Lucas Montarce as its new CFO amid regulatory challenges. The company is under pressure due to potential rejection of its Alzheimer's drug by the NHS and is combating imitation drugs. The stock has surged 53.37% YTD.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 3:01 am

BABA

MA

Alibaba's Hong Kong shares rose over 4% after being included in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, allowing Mainland China investors greater access. This inclusion is expected to enhance liquidity and broaden Alibaba's investor base.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 2:59 am

BIIB

BMY

Senator Bernie Sanders criticized the U.S. healthcare system, highlighting the disparity in life expectancy between rich and poor Americans. He emphasized the high cost of healthcare and its financial burden on patients, mentioning companies like Biogen and Bristol-Myers Squibb for their high drug prices.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 2:12 am

META

Australia plans to introduce legislation banning children from using social media platforms like Meta's Instagram and Facebook, and TikTok, due to health concerns. The move follows criticism of social media companies and aims to address cyberbullying and harmful content exposure.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 2:02 am

SIRI

Trading for a certain asset was halted at 7:50:00 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:50 pm

PBM

Psyence Biomedical Ltd. (NASDAQ:PBM) has launched its first clinical trial site in Australia for a Phase IIb study on psilocybin as a treatment for Adjustment Disorder in palliative care patients. This marks a significant step in advancing psychedelic-based treatments, with patient screening starting immediately and data expected by 2025.

Portfolio Pulse from Juan Spínelli

September 09, 2024 | 10:02 pm

SPRY

ARS Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) for neffy 1 mg, aimed at treating Type I allergic reactions, including anaphylaxis, in children weighing 15 to 30 kg.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:49 pm